- Cost of Hepatitis C Drug Price Skyrockets 1,422% after Patent Approval https://www1.folha.uol.com.br/internacional/en/scienceandhealth/2019/10/cost-of-hepatitis-c-drug-price-skyrockets-1422-after-patent-approval.shtml 328 comments worldnews
- Brazilian officials have accused US pharmaceutical company Gilead of abusing patent rights with its hepatitis C drug sofosbuvir. Since January, when Gilead received a patent for the sofosbuvir drug, the price of the drug has increased by 1,421.55% https://www1.folha.uol.com.br/internacional/en/scienceandhealth/2019/10/cost-of-hepatitis-c-drug-price-skyrockets-1422-after-patent-approval.shtml 4 comments worldnews
Linking pages
Linked pages
- Yanomami Health Units Have Feces, Expired Medicines, and Reused Syringes, Points Out Report - 07/02/2023 - Science and Health - Folha https://www1.folha.uol.com.br/internacional/en/scienceandhealth/2023/02/yanomami-health-units-have-feces-expired-medicines-and-reused-syringes-points-out-report.shtml 2 comments
Related searches:
Search whole site: site:www1.folha.uol.com.br
Search title: Cost of Hepatitis C Drug Price Skyrockets 1,422% after Patent Approval - 22/10/2019 - Science and Health - Folha
See how to search.